CRISIL Ltd. Downgraded to Sell Amid Technical Weakness and Valuation Concerns

Quality Assessment: Strong Management Efficiency but Growth Concerns

CRISIL continues to demonstrate robust management efficiency, reflected in its high return on equity (ROE) of 28.6%, which is a commendable figure within the capital markets industry. The company remains net-debt free, underscoring a solid balance sheet and prudent financial management. However, the long-term growth trajectory raises concerns. Over the past five years, net sales have grown at a modest compound annual growth rate (CAGR) of 13.7%, which is below expectations for a mid-cap company in this sector. This slower growth rate has contributed to the cautious stance on the stock’s quality, despite operational strengths.

Valuation: Expensive Metrics Amid Fair Peer Comparison

Valuation metrics for CRISIL indicate a relatively expensive stock. The company trades at a price-to-book (P/B) ratio of 9.8, which is high compared to typical industry standards. While this valuation is in line with the historical averages of its peers, it suggests limited upside potential given the current price levels. The price-to-earnings growth (PEG) ratio stands at 1.9, signalling that the stock’s price may not be fully justified by its earnings growth rate. Despite a strong ROE of 25.3% reported recently, the elevated valuation multiples have contributed to the downgrade, as investors weigh the risk of overpaying for future growth that appears subdued.

Financial Trend: Mixed Signals from Quarterly Performance and Returns

CRISIL’s financial performance in the quarter ending March 2026 was encouraging, with net sales rising 30.06% year-on-year to ₹1,057.66 crores and profit after tax (PAT) surging 45.9% to ₹233.26 crores. Profit before tax excluding other income also grew by 38.48% to ₹272.37 crores. These figures highlight operational resilience and effective cost management. However, the stock’s price performance tells a different story. Over the past year, CRISIL’s share price has declined by 32.72%, significantly underperforming the broader BSE Sensex, which fell 8.09% in the same period. The stock has also lagged the BSE500 index over the last three years and three months, indicating persistent underperformance despite improving profitability.

Technical Analysis: Shift to Bearish Momentum

The downgrade to Sell was primarily driven by a deterioration in technical indicators. CRISIL’s technical trend has shifted from mildly bearish to outright bearish, signalling increased downside risk. Key technical metrics reveal a mixed but predominantly negative outlook:

• MACD: Weekly readings remain mildly bullish, but monthly MACD is bearish, indicating weakening momentum over the longer term.
• RSI: The weekly Relative Strength Index is bearish, suggesting selling pressure in the near term, while the monthly RSI shows no clear signal.
• Bollinger Bands: Both weekly and monthly Bollinger Bands indicate bearish trends, reflecting increased volatility and downward price pressure.
• Moving Averages: Daily moving averages are bearish, reinforcing the short-term negative sentiment.
• KST (Know Sure Thing): Weekly KST is mildly bullish, but monthly KST remains bearish, highlighting conflicting signals across timeframes.
• Dow Theory: Weekly data shows mild bullishness, but monthly trends lack a clear direction.
• On-Balance Volume (OBV): Weekly OBV is mildly bullish, but monthly OBV shows no trend, indicating uncertain volume support.

These mixed but predominantly negative technical signals have contributed to the decision to downgrade the stock’s rating, as the price currently trades at ₹4,083.65, close to its 52-week low of ₹3,689.00 and well below its 52-week high of ₹6,329.95. The stock’s day range on 2 July 2026 was ₹4,072.00 to ₹4,215.50, reflecting limited upward momentum.

Comparative Returns: Underperformance Against Benchmarks

CRISIL’s stock returns have lagged key market indices over multiple time horizons. While the stock generated a modest 3.26% return over the past month, it underperformed the Sensex’s 3.58% gain. Year-to-date, CRISIL’s return stands at -5.58%, better than the Sensex’s -9.74%, but the one-year return of -32.72% is significantly worse than the Sensex’s -8.09%. Over three years, CRISIL’s 4.56% return pales in comparison to the Sensex’s 18.86%, and even over five years, while CRISIL has delivered a 58.59% return, it trails the Sensex’s 47.03% gain. The ten-year return of 99.46% is also well behind the Sensex’s 183.38%, underscoring the stock’s relative underperformance in the long term.

Summary and Outlook

CRISIL Ltd.’s downgrade to a Sell rating reflects a confluence of factors that weigh on its investment appeal. Despite strong management efficiency and encouraging quarterly financial results, the company faces challenges in sustaining long-term growth and justifying its elevated valuation multiples. The technical landscape has shifted decisively towards bearishness, signalling increased risk for investors. Additionally, the stock’s persistent underperformance relative to major indices and peers further dampens enthusiasm.

Investors should carefully consider these factors in the context of their portfolios and risk tolerance. While CRISIL remains a well-managed company with solid fundamentals, the current market signals and valuation concerns suggest a cautious approach. Monitoring upcoming quarterly results and technical developments will be crucial for reassessing the stock’s prospects in the near term.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →